0001367644-21-000075.txt : 20210511
0001367644-21-000075.hdr.sgml : 20210511
20210511161825
ACCESSION NUMBER: 0001367644-21-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210510
FILED AS OF DATE: 20210511
DATE AS OF CHANGE: 20210511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SULLIVAN LOUIS W
CENTRAL INDEX KEY: 0001193522
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 21911552
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN LOUIS
DATE OF NAME CHANGE: 20020927
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_162076428587593.xml
FORM 4
X0306
4
2021-05-10
0
0001367644
Emergent BioSolutions Inc.
EBS
0001193522
SULLIVAN LOUIS W
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2021-05-10
4
M
0
10305
18.64
A
43063
D
Common Stock
2021-05-10
4
F
0
3118
61.62
D
39945
D
Employee Stock Options (Right to Buy)
18.64
2021-05-10
4
M
0
10305
0
D
2017-05-21
2021-05-21
Common Stock
10305.0
0
D
Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock option exercise.
Consists of an option granted under the company's stock incentive plan as amended and restated.
The option vested in three equal installments in May 2015, May 2016 and May 2017. Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
/s/ Scott Lieberman, Attorney-in-fact
2021-05-11